Updated on 2 July 2014
The three-day show, Interphex and Inpharma trade show in Tokyo provides a platform for over 100 Indian companies to connect with the Japanese market
Singapore: The Indian Department of Commerce is showcasing the achievement of the country's pharmaceutical sector at the ‘Brand India Pharma' show in the Tokyo fair.
The three-day show, Interphex and Inpharma trade show in Tokyo provides a platform for over 100 Indian companies to connect with the Japanese market and showcase manufacturing and research capabilities of the country's pharmaceutical industry.
The Indian government, in a bid to highlight the value proposition that the country's pharma sector presents to the global market, has come up with this campaign.
The Indian Commerce Secretary, Mr Rajeev Kher, led the country's delegation to the trade exhibition. Mr Habil Khorakiwala, Chairman of Wockhardt headed the industry delegation, the Federation of Indian Chambers of Commerce and Industry (FICCI) said in a news statement.
"Given the heavy pressure on the health requirements, especially its ageing population, Japan, which is a USD 119 billion market, of which generics constitute 11 percent, decided to enlarge its generics portfolio. Japan represents an opportunity for the Indian pharmaceutical industry," it explained.
FICCI further added, "Under India's Comprehensive Economic Partnership Agreement (CEPA) with Japan, which is a conscious agreement to mutually increase cooperation in the pharma sector, Japan has extended national treatment to Indian companies."